MAVS Antikörper (AA 3-100)
Kurzübersicht für MAVS Antikörper (AA 3-100) (ABIN753133)
Target
Alle MAVS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 3-100
-
Verwendungszweck
- MAVS Polyclonal Antibody
-
Kreuzreaktivität
- Maus
-
Homologie
- Human,Rat,Cow
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human MAVS
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:300-5000),
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- MAVS (Mitochondrial Antiviral Signaling Protein (MAVS))
-
Andere Bezeichnung
- MAVS
-
Hintergrund
-
Synonyms: CARD adapter inducing interferon beta, Card, Interferon beta promoter stimulator protein 1, Interferon-beta promoter stimulator protein 1, Ips 1, Ips1, KIAA1271, Mitochondrial anti viral signaling protein, Mitochondrial Antiviral Signaling, Mitochondrial antiviral signaling protein, Putative NF kappa B activating protein 031N, Virus induced signaling adapter, DKFZp547C224, DKFZp666M015, FLJ27482, FLJ31698, FLJ35386, FLJ38051, CARD, FLJ41962, IPS-1, IPS1, MGC3260, VISA, MAVS_HUMAN.
Background: MAVS (Mitochondrial Antiviral Signaling) mediates the activation of NF-kappaB and IRF3 in response to antiviral infection. Silencing of MAVS expression permits derepression of viral replication, while over expression of MAVS boosts antiviral immunity.
-
Gen-ID
- 5788
-
Pathways
- Activation of Innate immune Response, Inositol Metabolic Process, Hepatitis C
Target
-